Respiratory Muscle Strength and Function in Healthy Kids
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Respiratory muscle strength training (RMST) is a potential treatment option that has been shown to increase strength and ventilatory function in critically ill patients, patients on ventilators and patients with mild neuromuscular weakness. Currently researchers are examining the role of inspiratory muscle strength training (IMST) in pressure performance of ventilator dependent children with Pompe disease. However, normal pressure-flow-timing responses of lung function are not well-characterized in healthy children. The purpose of this study is to measure RMST-induced changes in respiratory function in healthy children. Children will undergo one session of lung function and strength testing. By studying healthy children's respiratory function, this study will also help to develop more efficient respiratory muscle training exercise prescriptions for children with neuromuscular weakness and impaired respiratory function.
| Condition |
|---|
|
Respiratory Muscle Strength |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Prospective |
| Official Title: | Respiratory Muscle Strength and Function in Healthy Children |
- Pulmonary Function Testing [ Time Frame: Day 1 ] [ Designated as safety issue: No ]Subjects will complete tidal flow-volume assessments and forced expiratory maneuvers.
| Estimated Enrollment: | 30 |
| Study Start Date: | April 2011 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Respiratory Function
Children will undergo one session of pulmonary function and strength testing
|
Detailed Description:
The goals of this study are to collect and evaluate respiratory muscle strength training (RMST) induced changes in ventilatory function in healthy children. Children will undergo one session of pulmonary function and strength testing to quantify rate of inspiratory and expiratory pressure development and to determine whether inspiratory and expiratory pressure correlate to maximal respiratory pressures and forced pulmonary function tests. Currently normal pressure-flow-timing responses are not well-characterized in healthy children. The purpose of this study is to help develop more efficient RMST exercise prescriptions for ill children on ventilators and with neuromuscular weakness.
Participants in the study will refrain from caffeine products and exercise on the day of respiratory testing. In conjunction with respiratory testing, baseline and exertional blood pressure, heart and respiratory rate, and pulse oximetry will be monitored. Participants will complete tidal flow-volume assessments and forced expiratory maneuvers according to the AMerican Thoracic Society guidelines. Participants will undergo 5 sets of 10 maximal-effort breaths against standardized resistances (one set each at 0, 5, 10, 15, and 20 cm H20). Following each set, subjects will rate the load magnitude and their feelings of breathing discomfort using a 0-10 visual analog scale. Participants will also perform maximal inspiratory and expiratory pressure maneuvers. All tests will be separated by at least 2-3 minutes of rest.
Eligibility| Ages Eligible for Study: | 4 Years to 16 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Healthy Children
Inclusion Criteria:
- Male or female subjects 4-16 years of age.
- Healthy subjects
Exclusion Criteria:
- Have primary pulmonary disease
- Have primary neuromuscular disease
- Have a connective tissue or autoimmune disease
- Have had a respiratory infection with in 15 days prior to study date
- Have acute aminoglycosides antibiotic therapy with in 15 days prior to study date
- Have acute corticosteroids with in 15 days prior to study date
- Have a need to use an inhaler routinely
- Have hepatic failure
- Have hematologic failure
- Have participated in other studies related to medications or exercise
- Have used tobacco products
- Have other precautions
Contacts and Locations| Contact: Donna Johns | (352) 392-7861 | donnajohns@ufl.edu |
| Contact: Lee Ann Lawson, ARNP | (352) 575-0852 | llawson@pedcard.ufl.edu |
| United States, Florida | |
| University of Florida | Recruiting |
| Gainesville, Florida, United States, 32610 | |
| Contact: Barb K Smith, PT, PhD 352-273-7230 bksmith@phhp.ufl.edu | |
| Contact: Donna Johns (352) 392-7861 donnajohns@ufl.edu | |
| Principal Investigator: Barbara K Smith, PT, PhD | |
| Sub-Investigator: Barry J Byrne, MD, PhD | |
| Sub-Investigator: Lee Ann Lawson, ARNP | |
| Principal Investigator: | Barbara K Smith, PT, PhD | University of Florida |
More Information
Publications:
| Responsible Party: | University of Florida |
| ClinicalTrials.gov Identifier: | NCT01436318 History of Changes |
| Other Study ID Numbers: | HK 176-2011 |
| Study First Received: | September 16, 2011 |
| Last Updated: | November 28, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Florida:
|
Healthy Kids Respiratory Volunteers |
ClinicalTrials.gov processed this record on May 19, 2013